Clever Leaves Holdings Inc.
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$350
Cash Runway
—
Lead Asset
apas compact with urine analysis module
Next Catalyst
—
Tracking 4 pipeline candidates for Clever Leaves Holdings Inc. · Updated within the last hour.
Go deeper on Clever Leaves Holdings Inc. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on CLVR — live, with citations.
Score breakdownBased on 2 of 6 signals · derived from public data
Cash runway data unavailable
D/E 0.29 · 0% dilution
No tracked pipeline phase
4 candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Key Financialsas of December 31, 2023
Cash
$6.9M
Free Cash Flow
-$12K
Total Liabilities
$7.0M
Shareholders Equity
$24.2M
Current Ratio
2.40
Pipeline (4 candidates)
Commercialization & Governance
Commercialization
- Partnerships
- Cansativa GmbH (strategic investment; holdings sold in 2023); InterCure (agreement to import and distribute products in Israel); licensing partnerships in Germany including an unnamed global pharmaceutical company; Herbal Brands, Inc. (wholly owned subsidiary for nutraceutical distribution to >20,000 U.S. retail locations, subsequently sold); various retail distributors, pharmaceutical and cannabis companies, and pharmacies as customers/distribution partners.
- Launch Markets
- AustraliaBrazilGermanyIsraelUnited KingdomUnited States
- Commercial Strategy
- Partner with cannabis and pharmaceutical businesses by providing lower-cost product, variable cost structures, reliable year-round supply and accelerated speed to market using Colombian production footprint and pharma-grade (EU GMP, GACP, other) certifications. Structure sales regionally (Australia, Germany, Israel, Latin America, United Kingdom, United States and rest of world) across two primary distribution channels: wellness products and pharmaceutical products. Expand pharmaceutical distribution channel leveraging EU GMP and other certifications to access higher-margin markets with longer sales cycles. Utilize exports and strategic distribution partnerships to enter markets.
Governance
- Board Size
- 5
- Independent Pct
- 80%
Frequently asked questions
Who is the CEO of Clever Leaves Holdings Inc.?
Mr. Andres Fajardo is the chief executive officer of Clever Leaves Holdings Inc. (CLVR).
Where is Clever Leaves Holdings Inc. headquartered?
Clever Leaves Holdings Inc. (CLVR) is headquartered in Tocancipá, Colombia.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on Clever Leaves Holdings Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.